Grant✓ Small businesses may apply
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
Award ceiling
$750,000
Program funding
$750,000
- Opportunity #
- PAR-25-060
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.853
- Status
- posted
- Posted
- Oct 22, 2024
- Closes
- Oct 20, 2027
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Small businesses
- •City or township governments
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Private institutions of higher education
- •For profit organizations other than small businesses
- •County governments
- •Native American tribal governments (Federally recognized)
- •Special district governments
- •Public and State controlled institutions of higher education
- •Independent school districts
- •Public housing authorities/Indian housing authorities
- •State governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Synopsis
This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a significant improvement in the translational relevance of animal models or ex vivo systems that will be utilized to facilitate future development of neurotherapeutics. Ideally, models proposed for this FOA would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Program focused on enabling the exploratory and early stages of drug discovery.
Contact
National Institutes of Health · grantsinfo@nih.gov